Topic
Neoadjuvant Immunotherapy
6 Podcasts • 6 Cases on BackTable
Hear how experienced physicians approach Neoadjuvant Immunotherapy on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering patient selection, workup, and procedure technique. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 84 • 06 Oct 2026
Managing Refractory MSS-MCRC: Advanced Treatment Strategies
What options remain when a patient with microsatellite stable metastatic colorectal cancer (MSS mCRC) has progressed through every standard line of chemotherapy? On this episode of BackTable Tumor Board, Dr. Jun Gong is joined by Dr. Ibrahim Sahin and Dr. Sandra Algaze to explore the nuances of late-line management in MSS-mCRC. They discuss how to approach oxaliplatin retreatment and anti-EGFR rechallenge, the growing role of liquid biopsy and biomarker-driven selection, and the practicalities of DPYD testing after recent guideline changes.
More on Neoadjuvant Immunotherapy
Loading recent podcasts…
Tumor Board # 84
Oct 5, 2026
with Dr. Ibrahim Sahin, Dr. Sandra Algaze, Dr. Jun Gong
What options remain when a patient with microsatellite stable metastatic colorectal cancer (MSS mCRC) has progressed...
Tumor Board # 43
Jan 12, 2026
with Dr. Jun Gong, Dr. Jonathan Mizrahi
Get caught up on the cutting edge colorectal cancer trial data from ESMO 2025 with this 30-minute BackTable Tumor Board...
Tumor Board # 32
Oct 27, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri, Dr. Adam Luginbuhl
While the standard for adjuvant head and neck cancer treatment hasn't changed since 2004, a new trial using...
Tumor Board # 59
May 11, 2026
with Dr. Jonathan Mizrahi, Dr. Lingling Du, Dr. Craig Lockhart
With new systemic and liver-directed approaches under investigation, which targets and treatment strategies are most...
ENT & Allergy # 247
Nov 10, 2025
with Dr. Mihir Patel, Dr. Siddharth Sheth, Dr. Jennifer Johnson, Dr. Adam Luginbuhl
When treating head and neck cancer, how can you tell the difference between true disease progression and...
1,200+ listens
ENT & Allergy # 245
Oct 27, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri, Dr. Adam Luginbuhl
While the standard for adjuvant head and neck cancer treatment hasn't changed since 2004, a new trial using...
2,900+ listens
Tumor Board Case
Oct 27, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
Tumor Board Case
Oct 27, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
ENT Case
Oct 27, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
Tumor Board Case
Oct 27, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
ENT Case
Oct 27, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
ENT Case
Oct 27, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.